Our mission
Help biotechs move faster than they thought possible.
Why we built Tabulous
We're Ph.D scientists from Berkeley who previously built a biotech startup and raised over $100 million to bring a novel therapeutic to Phase II trials. Throughout our journey, we ran into the same problem over and over: legacy ELNs and LIMS that slowed us down.
So we built the tool we wished we'd had: Tabulous. A flexible, AI-powered platform that scientists actually love to use. No vendor lock-in. No six-month onboarding. No outrageous pricing. Just clean, reproducible experimental data from day one.
Now we're on a mission to help every biotech move faster than they thought possible.
It turns out the frustration we faced is everywhere. After adopting Tabulous, customers often eliminate entire toolchains: Legacy ELN or LIMS deployments, dated inventory solutions, Airtable, Jupyter Hub, GraphPad Prism, and Notion, to name a few.
We're just getting started, but Tabulous is already accelerating science across industries: Customers report 20%+ efficiency gains, 80% drop in analysis time and six-figure annual savings.
Curious to see if we can help you too? Book a working session with us! We'd love to learn about your setup and show you what's possible in Tabulous.
Investors
Backed by leading biotech investors.
We are fortunate to be backed by investors who understand the unique challenges of biotech and the importance of accelerating scientific discovery.
Venture Capital & Accelerators
Bee Partners is an early-stage venture capital fund that invests in exceptional entrepreneurs building transformative companies. They focus on supporting founders with deep technical expertise and provide hands-on guidance to help biotech startups navigate complex regulatory and market challenges.
Berkeley House Fund is UC Berkeley's premier startup accelerator, supporting the world's most promising entrepreneurs. As part of the Berkeley ecosystem, Berkeley House Fund provides access to world-class research, talent, and resources that are essential for deep-tech biotech startups.
Juniper Capital is a leading venture capital firm focused on early-stage biotech and life sciences companies. They bring deep domain expertise and a network of industry leaders to help portfolio companies scale and succeed in the competitive biotech landscape.